Addex Therapeutics Ltd (SWX:ADXN)
0.0580
-0.0020 (-3.33%)
Jul 21, 2025, 5:30 PM CET
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
123.09K CHF
Profits / Employee
4.34M CHF
Market Cap
5.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,249 |
Novartis AG | 75,883 |
Lonza Group AG | 18,944 |
Alcon | 25,599 |
Galderma Group AG | 6,545 |
Sandoz Group AG | 22,049 |
Straumann Holding AG | 11,815 |
Sonova Holding AG | 18,366 |
Addex Therapeutics News
- 21 days ago - Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs - GlobeNewsWire
- 21 days ago - Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders - GlobeNewsWire
- 26 days ago - Addex Shareholders Approve All Resolutions at Annual General Meeting - GlobeNewsWire
- 4 weeks ago - Earnings Scheduled For June 19, 2025 - Benzinga
- 4 weeks ago - Addex Therapeutics GAAP EPS of -CHF 0.01, income of CHF 0.07M - Seeking Alpha
- 4 weeks ago - Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewsWire
- 6 weeks ago - Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models - GlobeNewsWire